PCA analysis and differential expression analysis
This study first performed PCA analysis on the gene expression profiles of RNA-seq data from 155 cases of GBM patient cancer tissues and 5 cases of normal para-cancerous tissues (Fig. 1A). PC1 and PC2 accounted for more than 45% of the variation in the principal components, of which PC1 accounted for 31.9%. PCA results show that Normal (para-cancerous tissues) and Tumor (cancer) samples can be clearly separated at PC1, proving that the sample data of different batches are highly stable. The DEG results between the Tumor group and the Normal group (Fig. 1B) showed that the expression levels of 2302 genes were up-regulated and the expression levels of 1907 genes were down-regulated in cancer tissues.
The expression of EIF2S2 gene in glioma tissue is significantly higher than that in normal tissue (p < 0.001) (Table S4) which can be used for subsequent statistical analysis of clinic pathological data. The expression level of EIF2S2 gene was not significantly related to the age (p = 0.060) and gender (p = 0.229) of GBM patients. And there was a significant association between tumor grade (p < 0.001) and tumor recurrence (p < 0.001) and EIF2S2 expression level (Table S5). These results indicate that the higher the expression level of EIF2S2, the greater the probability of tumor recurrence and the higher the tumor grade. Kaplan-Meier survival analysis found that the expression of EIF2S2 gene was significantly related to the overall survival (Fig. 1C) and disease-free survival (Fig. 1D) of GBM (p < 0.05). Patients with high expression levels of the EIF2S2 gene have significantly shorter overall survival and disease-free survival than patients with low expression levels of the EIF2S2 gene. Therefore, EIF2S2 could potentially serve as a prognostic biomarker in GBM, with higher expression levels predicting worse clinical outcomes.
Effect of RNA interference on EIF2S2 gene expression
This study used qRT-PCR to measure EIF2S2 mRNA levels in GBM cells (U251, SHG-44, U373, U87) and normal brain cells (HEB) (Fig. 2A). EIF2S2 expression was significantly higher in GBM cells than in HEB cells (p < 0.001), consistent with previous findings that EIF2S2 is elevated in GBM tissues compared to para-cancerous tissues. To assess shRNA-mediated silencing, three shRNA sequences (shEIF2S2-1, shEIF2S2-2, shEIF2S2-3) were tested in SHG-44 cells. ShEIF2S2-1 and shEIF2S2-2 effectively reduced EIF2S2 expression by 57.4% and 74.0%, respectively (p < 0.001) (Fig. 2B), while shEIF2S2-3 was ineffective. ShEIF2S2-1 exhibited the highest silencing efficiency, so we chose the shEIF2S2-1 plasmid for further experimental validation.
To investigate the infection efficiency of lentiviral vectors (shCtrl or shEIF2S2) in GBM cells, microscopy was performed 72 hours post-infection in SHG-44 and U251 cells (Fig. 2C-D). Fluorescence microscopy revealed an infection efficiency exceeding 80%, indicating effective vector function and successful introduction of shRNA. qRT-PCR analysis showed that EIF2S2/GAPDH mRNA levels were significantly lower in the shEIF2S2 group compared to the shCtrl group (p < 0.001) in both SHG-44 (Fig. 2E) and U251 (Fig. 2F) cells. Silencing efficiencies were 87.00% in SHG-44 and 91.21% in U251 cells. Western blot results further confirmed significant down-regulation of EIF2S2 protein in the shEIF2S2 group relative to the shCtrl group (Fig. 2G-H), validating the effectiveness of shRNA-mediated EIF2S2 silencing.
EIF2S2 interference impairs GBM cell proliferation, induces apoptosis and inhibits migration
Previous research demonstrated that shEIF2S2 significantly impacts the mRNA and protein expression levels of EIF2S2 in SHG-44 and U251 cells. This study further explored the role of EIF2S2 in GBM cells through cell proliferation experiments (Fig. 3A-D). SHG-44 and U251 cells infected with shEIF2S2 displayed a significantly slower proliferation rate compared to the shCtrl group. Specifically, SHG-44 cells showed a fold change of 2.398 (p < 0.01), and U251 cells exhibited a fold change of 3.468 (p < 0.001). Additionally, flow cytometry revealed that both early and late apoptotic cell populations were significantly increased in the shEIF2S2 group compared to the shCtrl group (p < 0.01) (Fig. 3E-H). These results suggested that interference with EIF2S2 inhibits cell proliferation by promoting apoptosis.
Further analysis of the cell cycle distribution (Fig. 4A-D) indicated that EIF2S2 silencing in SHG-44 and U251 cells resulted in cell cycle arrest, with a significant reduction in the proportion of cells in the S phase and an increase in the proportion of cells in the G2 phase (p < 0.001). This cell cycle arrest was a critical factor contributing to the reduced proliferation observed. Wound healing (Fig. 4E-H) and Transwell assays (Figure S1A-D) demonstrated that EIF2S2 interference significantly inhibited the migration ability of SHG-44 and U251 cells. SHG-44 cells in the shEIF2S2 group showed an 87% reduction in migration rate (p < 0.001) in the wound healing assay, and a 44% reduction in the Transwell assay (p < 0.01). U251 cells exhibited a 36% reduction in migration rate in both assays (p < 0.01 and p < 0.001, respectively). These findings suggest that EIF2S2 plays a crucial role in the migration and invasiveness of GBM cells, with a more pronounced effect in SHG-44 cells.
Analysis of the expression level of the chip
To investigate downstream target genes regulated by EIF2S2, this study used human whole gene expression chips to analyze SHG-44 cells with shCtrl and shEIF2S. The relative logarithmic signal intensities for the NC and KD groups (Fig. 5A) showed that the median Z-scores were below 2, confirming good repeatability of the chip experiment. Intra-group correlation coefficients for KD and NC were over 0.99 (Fig. 5B), indicating high similarity in gene expression within each group, while inter-group coefficients were significantly lower, highlighting large group differences. PCA analysis showed PC1 and PC2 explained over 90% of the variation (Figure S2), with clear clustering of KD and NC samples. A total of 5630 differentially expressed genes (DEGs) were identified (Fig. 5C), with 2787 upregulated and 2843 downregulated. The heat map of the cluster analysis of significantly DEG in the chips of the NC group and the KD group (Fig. 5D) showed the differences between the shEIF2S2 group and the shCtrl group. This suggests that DEGs are likely associated with EIF2S2's cellular functions.
Classical path analysis of IPA
Enrichment analysis of DEGs using Ingenuity Pathway Analysis (IPA) revealed that these genes are primarily involved in pathways such as Cholesterol Biosynthesis (I, II, and III), Aryl Hydrocarbon Receptor Signaling, Cell Cycle Control, NF-kB Signaling, and Xenobiotic Metabolism CAR Signaling (Fig. 6A).These results reveal that the EIF2S2 gene is shown to exert its role in cellular function through these key biological processes and signaling pathways.
Disease and function enrichment analysis (Fig. 6B) identified major categories including cancer, organismal injury, endocrine system disorders, gastrointestinal and reproductive system diseases, neurological diseases, and cell survival. These findings suggest that EIF2S2 interference affects crucial biological processes and disease-related pathways, notably cancer. A network relationship analysis (Figure S3) showed that EIF2S2 interacts with various signaling pathways such as ATM Signaling, EIF2 Signaling, ERK/MAPK Signaling, mTOR Signaling, Senescence Pathway and AMPK Signaling. EIF2S2 influences genes like ATF2, CDK1, DLD, EIF2B5 and EIF3J by affecting the expression of genes involved in these pathways, including APP, BIRC3, CUL7, EIF2B5, EIF3M, and G3BP1.
Analysis of downstream targeted genes
This study identified five potential EIF2S2 downstream target genes through IPA pathway analysis, namely Cluster of Differentiation 44 (CD44), DEP Domain Containing 1B (DEPDC1B), Matrix Metalloproteinase 7 (MMP7), Myeloid Differentiation Primary Response 88 (MYD88), Wingless-Type MMTV Integration Site Family, Member 5A (WNT5A). Western blot results (Fig. 7A) showed no change in MMP7 and MYD88 protein levels between SHG-44 cells with shCtrl and shEIF2S2. However, CD44 protein levels were higher in SHG-44 with shCtrl, while DEPDC1B and WNT5A levels were lower compared to shEIF2S2. Additionally, WNT5A mRNA expression in SHG-44 cells aligned with EIF2S2 mRNA expression.MeRIP-qRT-PCR experiments further revealed that WNT5A gene interference significantly reduced the m6A level of the EIF2S2 gene (Fig. 7C). And the interaction diagram between EIF2S2 and APP, BIRC3, CUL7, EIF2B5, EIF3M, and WNT5A genes (Fig. 7D) also shows that the WNT5A gene is a key downstream target gene of the EIF2S2 gene.
Reaction experiment to verify downstream genes
This study examined the effects of three shRNA sequences (shEIF2S2-1, shEIF2S2-2, shEIF2S2-3) on WNT5A expression in SHG-44 cells (Figure S4). Post-lentiviral infection, WNT5A knockout rates were 93.5% for shWNT5A-1, 75.1% for shWNT5A-2, and 87.6% for shWNT5A-3 (p < 0.001). The highest knockout efficiency was observed with shWNT5A-1, which was selected for further experiments. To explore the infection efficiency of shWNT5A-1 and EIF2S2 plasmids in GBM cells, SHG-44 and U251 cells were observed under a microscope after 72 hours of infection (Fig. 8A-B). Fluorescence indicated over 80% infection efficiency, confirming the functionality of the lentiviral vectors. MRNA expression levels of EIF2S2/GAPDH and WNT5A/GAPDH were assessed in SHG-44 and U251 cells (Figs. 8C-F). In the EIF2S2 + NC (KD) group, EIF2S2 and WNT5A mRNA levels significantly increased (p < 0.001), while in the shWNT5A + NC (OE) group, both decreased significantly (p < 0.05). In the EIF2S2 + shWNT5A group, WNT5A mRNA levels significantly decreased (p < 0.001), but EIF2S2 levels remained unchanged. Conversely, in the shWNT5A + NC (OE) group, EIF2S2 mRNA levels increased significantly, while WNT5A decreased (p < 0.05). These results suggest a mutual regulatory relationship between EIF2S2 and WNT5A. Western blot analysis (Figs. 8G-H) showed that in SHG-44 cells, EIF2S2 protein levels significantly increased in the EIF2S2 + NC (KD) group, while WNT5A decreased. In the shWNT5A + NC (OE) group, WNT5A decreased significantly, with no significant change in EIF2S2. In U251 cells, the EIF2S2 + NC (KD) group showed a significant increase in EIF2S2 protein without a significant change in WNT5A. In the shWNT5A + NC (OE) group, both proteins decreased significantly. These findings reinforce the mutual regulatory relationship between EIF2S2 and WNT5A.
To further explore the effects of EIF2S2 and WNT5A genes on GBM cells, this study conducted apoptosis and wound-healing assay experiments (Fig. 9). In SHG44 cells (Fig. 9A, 9C) and U251 cells (Fig. 9B, 9D), compared with the NC(OE + KD) group, the cell apoptosis in the EIF2S2 + NC (KD) group was reduced (P < 0.001). Compared with the NC (OE) + KD group, the cell apoptosis in the shWNT5A + NC(OE) group was significantly increased (p < 0.05). Compared with the EIF2S2 + NC (KD) group, the cell apoptosis in the EIF2S2 + shWNT5A group was significantly increased (p < 0.001). Compared with the shWNT5A + NC (OE) group, the cell apoptosis in the EIF2S2 + shWNT5A group was reduced (p < 0.001). These results reveal the complex interaction between EIF2S2 and WNT5A in regulating apoptosis, providing important clues for further understanding their roles in cell biological functions.
The scratch healing assay in SHG-44 cells (Fig. 9E, 9G) showed that the cell migration rate in the EIF2S2 + NC (KD) group was significantly increased compared with the NC (OE + KD) group (p < 0.05). There was no significant difference in the cell migration rate in the shWNT5A + NC (OE) group compared with the NC (OE + KD) group. Further comparison showed that the cell migration rate in the EIF2S2 + shWNT5A group was significantly decreased compared with the shWNT5A + NC (OE) group (p < 0.05). The cell migration rate in the EIF2S2 + shWNT5A group (24 hours) was significantly increased compared with the EIF2S2 + NC(KD) group (p < 0.05). The scratch healing assay in U251 cells (Fig. 9F, 9H) found that there was no significant difference in the cell migration rate among the groups.